Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT07109427
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
40 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Annual PSA Health Maintenance Reminder — OTHER
    The annual health maintenance reminder does not mandate PSA screening for eligible patients. Instead, it recommends that primary care providers (PCPs) initiate a shared decision-making discussion with their patients. As part of this conversation, patients will be informed of their individual risk factors-including race, family history, and germline mutations-and can then make an informed choice about whether to proceed with PSA screening.

Study Details

\- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care: * Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines. * Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices. * The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.

Key Dates

Start date
Aug 11, 2025
Status verified
Aug 2025
Primary completion
Aug 31, 2031
Completion
Aug 31, 2031

Study Design

Enrollment
40,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Annual PSA Health Maintenance Reminder
    An annual health maintenance reminder will be implemented for all men who meet the American Cancer Society guidelines for average- and high-risk eligibility criteria. The goal is to encourage their primary care provider (PCP) to engage in a shared decision-making discussion with the patient about the benefits and risks of prostate cancer screening. This alert will appear in the health maintenance reminder section of the electronic health record (EHR). Although all providers with access to EPIC can view the alert, it is typically the PCPs who review and take action on alerts in the health maintenance reminder section.

Primary Outcome Measure

Change in PSA screening completion rates in the BJC East Health System [ Time Frame: Through 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University School of MedicineSt LouisMissouri63110
Lannis Hall, M.D., MPH
[email protected]
636-916-9947
Lannis Hall, M.D., MPH (PRINCIPAL_INVESTIGATOR)
Saira Khan, Ph.D., MPH (SUB_INVESTIGATOR)
Arnold Bullock, M.D. (SUB_INVESTIGATOR)
Timothy Eberlein, M.D. (SUB_INVESTIGATOR)
Kristina Williams (SUB_INVESTIGATOR)
Cliff Robinson, M.D. (SUB_INVESTIGATOR)
Jingqin (Rosy) Luo, Ph.D. (SUB_INVESTIGATOR)
Christopher Abraham, M.D. (SUB_INVESTIGATOR)
Michael Johnson, M.D. (SUB_INVESTIGATOR)

Find similar trials in St Louis, MO

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Washington University School of Medicine· St Louis, MO

Related Studies